This video has been created and funded by Biogen. For Healthcare Professionals only
Disclosures: Quiroga is on the speakers’ bureau, and/or consultant for Biogen, Idorsia, Casen-Recordati, Johnson & Johnson, Novartis, Takeda, Bial, Shire, Neuraxpharm, Novartis, BMS, Medice, Rubió, Uriach, TechnoFarma, and Raffo in the last 3 years; has received travel awards (air tickets + accommodation) for taking part in psychiatric meetings from Idorsia, Johnson & Johnson, Rubió, Takeda, Bial, and Medice; and The Department of Psychiatry chaired by Quiroga received unrestricted educational and research support from the following companies in the last 3 years: Exeltis, Idorsia, Johnson & Johnson, Neuraxpharm, Oryzon, Roche, Probitas, and Rubió.
Gomes has been a Speaker for Biogen, Abbott, Apsen, Daiichi-Sankyo, Eurofarma, GnTech, Janssen, Lundbeck, Torrent; provided Scientific Support to Apsen, Janssen, Lundbeck and sits on the Advisory Board for Biogen.
Cantilino has been a speaker for Biogen, Daiichi-Sankyo, EMS, Janssen, Libbs and is on the advisory board of Biogen and Viatris.
In this educational symposium from the 33rd European Congress of Psychiatry (EPA) 2025, Ramos Quiroga, Igor Emanuel, and Amaury Cantilino provide a holistic overview of postpartum depression (PPD), its negative consequences, and recognition and management.
Topics covered:
- What is PPD, and how common is it?
- How can PPD develop?
- What are the consequences of PPD?
- What can we do to detect and manage PPD?
Speakers
Jose Antonio Ramos Quiroga1
Igor Emanuel Vasconcelos e Martins Gomes2
Amaury Cantilino3
1. University Hospital Vall d’Hebron, Autonomous University of Barcelona, Spain
2. I Psi Clinic Fortaleza, Brazil
3. Clinical Hospital of the Federal University of Pernambuco, Recife, Brazil
Biogen-276726 | November 2025
